BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38947352)

  • 1. Epidemiology and antimicrobial resistance of
    Thomsen J; Abdulrazzaq NM; Nyasulu PS; Al Hosani F; Habous M; Weber S; Jabeen F; ; Menezes GA; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2024; 12():1244353. PubMed ID: 38947352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving trends among
    Thomsen J; Menezes GA; Abdulrazzaq NM; ; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1243973. PubMed ID: 38106909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and antimicrobial resistance trends of
    Thomsen J; Abdulrazzaq NM; AlRand H; ; Everett DB; Senok A; Menezes GA; Ayoub Moubareck C
    Front Public Health; 2023; 11():1245131. PubMed ID: 38239785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.
    Thomsen J; Abdulrazzak NM; AlRand H; ; Menezes GA; Moubareck CA; Everett DB; Senok A; Podbielski A
    Front Public Health; 2023; 11():1275778. PubMed ID: 38089023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Multi-Drug Resistant
    Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
    Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis and MDR-TB in the northern emirates of United Arab Emirates: a 5-year study.
    Al-Zarouni M; Dash N; Al Ali M; Al-Shehhi F; Panigrahi D
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):163-8. PubMed ID: 20578495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.
    Jabeen K; Shakoor S; Malik F; Hasan R
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase.
    Thomsen J; Abdulrazzaq NM; AlRand H;
    Front Public Health; 2023; 11():1247627. PubMed ID: 38074700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013.
    Areeshi MY; Bisht SC; Mandal RK; Haque S
    J Infect Dev Ctries; 2014 Sep; 8(9):1137-47. PubMed ID: 25212078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
    Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
    Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    Lobie TA; Woldeamanuel Y; Asrat D; Beyene D; Bjørås M; Aseffa A
    PLoS One; 2020; 15(4):e0231320. PubMed ID: 32267877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
    Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
    Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
    Al Ammari M; Al Turaiki A; Al Essa M; Kashkary AM; Eltigani SA; Ahmed AE
    Antimicrob Resist Infect Control; 2018; 7():12. PubMed ID: 29387346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial.
    Demers AM; Kim S; McCallum S; Eisenach K; Hughes M; Naini L; Mendoza-Ticona A; Pradhan N; Narunsky K; Poongulali S; Badal-Faesen S; Upton C; Smith E; Shah NS; Churchyard G; Gupta A; Hesseling A; Swindells S;
    BMC Infect Dis; 2021 Feb; 21(1):205. PubMed ID: 33627075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.